Helius Medical Technologies Inc represents values of innovation, excellence, and patient-centered care. With a strong corporate philosophy focused on advancing neurorehabilitation and improving patient outcomes, Helius Medical Technologies is committed to developing and delivering cutting-edge medical technologies. The company harnesses the power of its proprietary PoNS™ device, which combines neurostimulation with therapeutic exercises, to provide non-invasive treatment options for patients suffering from neurological symptoms. Helius Medical Technologies Inc strives to empower patients and healthcare providers with state-of-the-art solutions that have the potential to transform lives. Through dedication to research, development, and collaboration, the company aims to make a lasting and positive impact on the field of neurorehabilitation.

Helius Medical Technologies Inc is primarily present in the United States and Canada. As a leading medical technology company, Helius focuses on neurological wellness by developing and commercializing innovative products. With headquarters in Newtown, Pennsylvania, Helius operates in various regions across North America, aiming to provide advanced neurostimulation solutions. This includes the PoNS™ device, a non-invasive neuromodulation device for the treatment of neurological symptoms caused by disease or trauma. By combining medical expertise and cutting-edge technology, Helius Medical Technologies Inc contributes to improving patient outcomes throughout the United States and Canada.

Helius Medical Technologies Inc has achieved several significant milestones. One notable achievement is the FDA clearance of their PoNS™ device for the treatment of neurological symptoms caused by multiple sclerosis (MS) and traumatic brain injury (TBI). The company has also expanded its clinical trial programs and collaborations to further explore the potential of their innovative technology in other areas, such as stroke rehabilitation. Additionally, Helius Medical Technologies Inc has successfully raised capital to support its research and development efforts, demonstrating investor confidence in the company's vision and potential.

Helius Medical Technologies Inc is a leading neurotech company focused on developing groundbreaking non-invasive treatments. Founded in 2014, the company is driven by a mission to expand and advance the understanding, treatment, and application of neurological disorders. Helius Medical Technologies Inc is renowned for its innovative device, the Portable Neuromodulation Stimulator (PoNS), which has shown promising results in various clinical trials. This breakthrough technology aims to enhance neuroplasticity, encouraging healing and recovery for patients with neurological conditions. With a commitment to improving patients' quality of life, Helius Medical Technologies Inc continues to revolutionize the field of neuro-rehabilitation through cutting-edge innovations and research.

The main competitors of Helius Medical Technologies Inc in the market are NeuroMetrix, Inc and Neuromod Devices Limited.

Helius Medical Technologies Inc is primarily active in the healthcare industry.

Helius Medical Technologies Inc operates as a medical technology company. Its business model focuses on the development, licensing, and commercialization of neurological technologies. The company primarily offers its proprietary neurostimulation technology platform, known as PoNS™ (Portable Neuromodulation Stimulator), which is designed to enhance neural activity in the brain. Helius Medical Technologies aims to address unmet medical needs and provide innovative solutions for patients suffering from neurological symptoms caused by disease or trauma. With a strong commitment to research and development, the company strives to improve patient outcomes and advance the field of neurology.

Helius Medical Technologies의 P/E 비율은 -0.02입니다.

Helius Medical Technologies의 P/S 비율은 0.89입니다.

Helius Medical Technologies에 대한 AlleAktien 품질 점수는 3/10입니다.

예상되는 Helius Medical Technologies 매출은 477,360 USD입니다.

예상되는 Helius Medical Technologies 이익은 -18.41 백만 USD입니다.

The business model of Helius Medical Technologies focuses on the development and marketing of innovative products and services to improve the rehabilitation of neurological diseases. The company specializes in neurorehabilitation, offering a therapy called PoNS (Portable Neuromodulation Stimulator) that stimulates nerves in the brain through electronic impulses sent to the tongue. This therapy can improve motor and cognitive abilities in patients with conditions such as stroke, traumatic brain injury, or multiple sclerosis. Helius Medical Technologies is also involved in neuroscience research and development, collaborating with leading research institutions and clinical studies. Additionally, the company offers telemedicine services through their Helius Tele-Rehabilitation program, allowing patients to participate in therapy sessions from home using a PoNS stimulator and iPad. Overall, Helius Medical Technologies aims to continually innovate and expand its business through research and development, patent acquisition, and collaborations with clinicians and researchers. Its goal is to improve the lives of millions of individuals worldwide.

Helius Medical Technologies은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Helius Medical Technologies의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Helius Medical Technologies의 ISIN은 US42328V6039입니다.

Helius Medical Technologies의 WKN은 A2JB8E입니다.

Helius Medical Technologies의 티커는 HSDT입니다.

지난 12개월 동안 Helius Medical Technologies은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Helius Medical Technologies은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Helius Medical Technologies의 현재 배당 수익률은 입니다.

Helius Medical Technologies은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Helius Medical Technologies은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Helius Medical Technologies은 '건강' 섹터에 속합니다.

Helius Medical Technologies의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Helius Medical Technologies는 0 USD를 배당금으로 지급했습니다.

Helius Medical Technologies의 배당금은 USD에 지급됩니다.